The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Therapeutic Pipeline Program, 2015RQ-00000010 for Gastroparesis and Constipation in Parkinson’s Disease
Study Rationale:
Constipation and gastroparesis (slow stomach emptying) are common non-motor symptoms of Parkinson’s disease (PD). These symptoms cause troublesome gastrointestinal... -
Access to Data & Biospecimens, 2015Whole Genome Sequencing and Analysis of the PPMI Prodromal and Genetic Cohorts, PPMI Genetic Registry and the LRRK2 Cohort Consortium
Study Rationale:
This work aims to provide genetic information for the whole genome and assess the role of the identified genetic information in Parkinson disease. To do this...
-
Access to Data & Biospecimens, 2015Evaluation of Alpha-synuclein and Hemoglobin Levels in CSF, Plasma and Saliva samples from the BioFind Cohort
Study Rationale:
Alpha-synuclein pathology plays a major role in Parkinson’s disease (PD). Recent studies suggest that measurement of alpha-synuclein in biological fluids (e.g...
-
Research Grant, 2014Development of an MgluR4 PET Radioligand
Study Rationale:
mGluR4 is a glutamate receptor that is believed to be a potential therapeutic target for Parkinson’s disease (PD). Developing an imaging tracer may allow researchers... -
Rapid Response Innovation Awards, 2014Improving Gait in Parkinson’s Disease Patients by Non-invasive Electrical Stimulation of the Cerebellum
Study Rationale:
People with Parkinson’s disease (PD) can experience difficulties walking (e.g., freezing), which can lead to falls and negatively impact quality of life. These symptoms are difficult... -
Improved Neuromodulation Approaches, 2014Adaptive Closed Loop Neuromodulation and Neural Signatures of Parkinson’s Disease
Study Rationale:
Currently deep brain stimulation (DBS) is limited to “open-loop” stimulation, without real-time adjustment to the patient’s state of activity, fluctuations and types of motor symptoms...
![Two female doctors talking in the lab.](/sites/default/files/styles/ad_callout_single/public/images/ad/apply-for-grant-404-Large-Image-Callout-A-1.jpg?h=2a1ad497&itok=-_5jZ5iX)
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.